Keyrus Life Science
Thierry Dubon currently serves as the Director of the RWE Department at Keyrus Life Science, a position held since May 2021. From 2003 to May 2021, Thierry held various roles at EXCELYA, including Deputy Managing Director in Bordeaux and Managing Director, as well as responsibilities in Biometry and Late Phase studies. Additionally, Thierry was the President of AfrItec Côte d'Ivoire from August 2015 to May 2021, contributing to the establishment of the first CRO in Côte d'Ivoire, leveraging ITEC Services' 30 years of experience in France for local clinical and epidemiological studies. Thierry also served as CEO of Clinical Healthcare and Innovation for Africa (C.H.I.F.A) from July 2018 to February 2019.
This person is not in the org chart
This person is not in any teams
Keyrus Life Science
Keyrus Life Science is a Connected Contract Research Organization (C2RO), active for almost 25 years internationally, and part of the Keyrus group, an expert in data and digital solutions. Combining in-depth scientific and industry expertise, a deep understanding of life data sciences, and the integration of cutting-edge digital technologies, Keyrus Life Science optimizes the conduct of clinical trials and RWE projects, bringing greater agility and reliability, increasing their resilience and performance, and accelerating their execution. Keyrus Life Science supports life science industrials, such as the Pharmaceutical, Biotech et Medtech industries in their clinical R&D, in all types of therapeutic areas, thanks to a broad portfolio of services, available under 3 delivery models - Project, Service Platforms (FSP) and Consulting: • Frame clinical development strategies: Evaluation and execution of all key steps required to launch a robust clinical study. • Operationalize clinical development: Implementation of services and solutions necessary for the efficient management of clinical trials, including biostatistics or medical writing, without compromising on quality or on schedule, and within the established budget. • Implement RWE and Late Phase projects: Providing in-depth expertise and support from the design of the studies, through the implementation, to the valorization of the data collected. • Enable life data science boosters : Orchestrating data and technologies to improve patients' lives, facilitate the development of precision therapeutic solutions, make clinical research more translational, or develop more predictive medicine. • Reach the next level in digital innovation: Identification of innovative digital solutions to support the development of products or services in specific therapeutic areas or needs, in conjunction with strong technology partners. For more information on our expertises & know-hows, please visit https://keyruslifescience.com